Stockreport

Aerie Pharmaceuticals Initiates First-in-Human Clinical Trial of AR-13503 Sustained Release Intravitreal Implant in Patients with Neovascular Age-Related Macular Degeneration and Diabetic ...

Aerie Pharmaceuticals, Inc.  (AERI) 
Last aerie pharmaceuticals, inc. earnings: 2/20 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aeriepharma.com/investor-relations
PDF -- Study will evaluate the safety and preliminary efficacy of AR-13503 SR Implant as monotherapy and in combination with aflibercept -- DURHAM, N.C.--(BUSINESS WIRE)- [Read more]